Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (91-100 of 356) with videos related to

Pageof 36
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 7, 2006
The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year reportCarmine Tinelli, Annalisa De Silvestri, Luca Richeldi, et al.
BMJ Case Reports|December 7, 2019
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells usEnrica Intini, Girija Kishore, Luca Richeldi, et al.
Respirology (Carlton, Vic.)|March 3, 2015
Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspectiveYuben Moodley, Tamera Corte, Luca Richeldi, et al.
Expert Opinion on Pharmacotherapy|January 13, 2018
Nintedanib for the treatment of idiopathic pulmonary fibrosisFrancesco Varone, Giacomo Sgalla, Bruno Iovene, et al.
Inflammatory Bowel Diseases|November 3, 2021
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn's DiseaseCarmelo Sofia, Veronica Adiletta, Bruno Iovene, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2021
The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study ProtocolLuca Richeldi, Alessio Piraino, Francesco Macagno, et al.
The American Journal of the Medical Sciences|April 24, 2019
Current and Future Idiopathic Pulmonary Fibrosis TherapyLuca Richeldi, Fabiana Baldi, Giuliana Pasciuto, et al.
Respiratory Research|April 12, 2019
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trialsMichael Kreuter, Harald Koegler, Matthias Trampisch, et al.
Multidisciplinary Respiratory Medicine|November 14, 2012
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesPaolo Spagnolo, Roberto Tonelli, Elisabetta Cocconcelli, et al.
American Journal of Respiratory and Critical Care Medicine|March 24, 2020
Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for ResearchMichael S Niederman, Luca Richeldi, Sanjay H Chotirmall, et al.
Pageof 36

Showing results (91-100 of 356) with videos related to

Sort By:
Pageof 36
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 7, 2006
The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year reportCarmine Tinelli, Annalisa De Silvestri, Luca Richeldi, et al.
BMJ Case Reports|December 7, 2019
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells usEnrica Intini, Girija Kishore, Luca Richeldi, et al.
Respirology (Carlton, Vic.)|March 3, 2015
Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspectiveYuben Moodley, Tamera Corte, Luca Richeldi, et al.
Expert Opinion on Pharmacotherapy|January 13, 2018
Nintedanib for the treatment of idiopathic pulmonary fibrosisFrancesco Varone, Giacomo Sgalla, Bruno Iovene, et al.
Inflammatory Bowel Diseases|November 3, 2021
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn's DiseaseCarmelo Sofia, Veronica Adiletta, Bruno Iovene, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2021
The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study ProtocolLuca Richeldi, Alessio Piraino, Francesco Macagno, et al.
The American Journal of the Medical Sciences|April 24, 2019
Current and Future Idiopathic Pulmonary Fibrosis TherapyLuca Richeldi, Fabiana Baldi, Giuliana Pasciuto, et al.
Respiratory Research|April 12, 2019
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trialsMichael Kreuter, Harald Koegler, Matthias Trampisch, et al.
Multidisciplinary Respiratory Medicine|November 14, 2012
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesPaolo Spagnolo, Roberto Tonelli, Elisabetta Cocconcelli, et al.
American Journal of Respiratory and Critical Care Medicine|March 24, 2020
Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for ResearchMichael S Niederman, Luca Richeldi, Sanjay H Chotirmall, et al.
Pageof 36